CN108997216B - 高乌甲素晶体、制备方法、高乌甲素冻干粉针及制备方法 - Google Patents
高乌甲素晶体、制备方法、高乌甲素冻干粉针及制备方法 Download PDFInfo
- Publication number
- CN108997216B CN108997216B CN201810801535.7A CN201810801535A CN108997216B CN 108997216 B CN108997216 B CN 108997216B CN 201810801535 A CN201810801535 A CN 201810801535A CN 108997216 B CN108997216 B CN 108997216B
- Authority
- CN
- China
- Prior art keywords
- lappaconitine
- crystal
- freeze
- dried powder
- powder injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810801535.7A CN108997216B (zh) | 2018-07-20 | 2018-07-20 | 高乌甲素晶体、制备方法、高乌甲素冻干粉针及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810801535.7A CN108997216B (zh) | 2018-07-20 | 2018-07-20 | 高乌甲素晶体、制备方法、高乌甲素冻干粉针及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108997216A CN108997216A (zh) | 2018-12-14 |
CN108997216B true CN108997216B (zh) | 2020-10-30 |
Family
ID=64597213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810801535.7A Active CN108997216B (zh) | 2018-07-20 | 2018-07-20 | 高乌甲素晶体、制备方法、高乌甲素冻干粉针及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108997216B (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100409848C (zh) * | 2003-06-24 | 2008-08-13 | 汕头市八达制药有限公司 | 一种稳定的氢溴酸高乌甲素冻干粉针剂及其制备方法 |
CN102617468A (zh) * | 2012-03-07 | 2012-08-01 | 西北师范大学 | 一种超声辅助提取高乌甲素的方法 |
CN104688693B (zh) * | 2015-03-23 | 2017-04-26 | 山东北大高科华泰制药有限公司 | 注射用氢溴酸高乌甲素粉针剂药物组合物和制法 |
CN104876866A (zh) * | 2015-05-04 | 2015-09-02 | 陕西科技大学 | α晶型高乌甲素及其制备方法 |
-
2018
- 2018-07-20 CN CN201810801535.7A patent/CN108997216B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108997216A (zh) | 2018-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004226824B2 (en) | Quinoline-2-one-derivatives for the treatment of airways diseases | |
EP3502105B1 (en) | Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof | |
KR950702424A (ko) | 결정형 아미포스틴 조성물과 그 제조방법 또한 그 용도(Crystalline amifostine compositions and methods for the preparation and use of same) | |
WO2018076782A1 (zh) | 右旋奥拉西坦新晶型及其制备方法和用途 | |
WO2018076784A1 (zh) | (r)-4-羟基-2-氧代-1-吡咯烷乙酰胺晶型及其制备方法和用途 | |
WO2022007629A1 (zh) | 乌帕替尼的晶型及其制备方法和用途 | |
JP2019529504A (ja) | 非溶媒和物結晶及びその製造方法、並びに応用 | |
CN108997216B (zh) | 高乌甲素晶体、制备方法、高乌甲素冻干粉针及制备方法 | |
WO2015007129A1 (zh) | 一种(-)-石杉碱甲的制备 | |
JP2020504124A (ja) | (r)−4−ヒドロキシ−2−オキソ−1−ピロリジンアセトアミドの結晶形、その調製方法および使用 | |
JP6923122B2 (ja) | 難溶性複合物又はその溶媒和物、薬物組成物及びその応用 | |
CN104860832A (zh) | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物 | |
JP2024056724A (ja) | ムスカリン性アセチルコリン受容体アゴニストの結晶性多形 | |
CN108503560B (zh) | 柳胺酚晶型ii、其制备方法及其应用 | |
KR101095382B1 (ko) | 이리노테칸 염산염의 결정다형의 제조방법 | |
TWI656116B (zh) | Crystal form of 9-aminomethyl substituted tetracycline compound and preparation method thereof | |
US20200115321A1 (en) | Crystal form of dezocine and preparation method therefor | |
WO2022121854A1 (zh) | 2-羟基-5-[2-(4-(三氟甲基苯基)乙基氨基)]苯甲酸晶型及其制备方法 | |
CN108003101B (zh) | 石杉碱甲多晶型物及其制备方法和药用组合物 | |
WO2020244148A1 (zh) | 多拉菌素晶型a、晶型b及其制备方法 | |
WO2018222572A1 (en) | Non-covalent derivatives and methods of treatment | |
KR102544543B1 (ko) | L,d-엘도스테인의 개별적 공결정화물 | |
CN104829467A (zh) | 盐酸氨溴索二水化合物 | |
JP2954956B2 (ja) | 結晶(5r,6s)‐2‐カルバモイルオキシメチル‐6‐[(1r)‐ヒドロキシエチル]‐2‐ペネム‐カルボン酸及びその医薬処方物 | |
CN115925662A (zh) | 丹酚酸c的新晶型及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Caihong Inventor before: Zhao Caihong |
|
CB03 | Change of inventor or designer information | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Lappaconitine crystal, preparation method, Lappaconitine freeze-dried powder injection and preparation method Effective date of registration: 20220615 Granted publication date: 20201030 Pledgee: Shaanxi SME financing Company limited by guarantee Pledgor: XI'AN RAINBOW BIO-TECH Co.,Ltd. Registration number: Y2022980007910 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230116 Address after: 710000 2-2-2, Building 6, Science and Technology Enterprise Park, No. 2 West Qinling Avenue, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an, Shaanxi Province Patentee after: Shaanxi Jiaming Biotechnology Co.,Ltd. Address before: 710000 2-2-2, building 6, science and technology enterprise accelerator Park, west 2, Qinling Avenue, Caotang science and technology industrial base, high tech Zone, Yanta District, Xi'an City, Shaanxi Province Patentee before: XI'AN RAINBOW BIO-TECH Co.,Ltd. |
|
TR01 | Transfer of patent right |